Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging

No AccessJournal of Urology1 Feb 2017Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging Donald F. Gleason, George T. Mellinger, and The Veterans Administration Cooperative Urological Research Group† Donald F. GleasonDonald F. Gleason , George T. MellingerGeorge T. Mellinger , and The Veterans Administration Cooperative Urological Research Group† View All Author Informationhttps://doi.org/10.1016/j.juro.2016.10.099AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1 Evans, N., Barnes, R. W. and Brown, A. F.: Carcinoma of prostate; correlation between the histologic observations and clinical course. Arch. Path., 34: 473, 1942. Google Scholar 2 Thompson, G. J.: Transurethral resection of malignant lesions of the prostate gland. J.A.M.A., 120: 1105, 1942. Google Scholar 3 Pool, T. L. and Thompson, G. J.: Conservative treatment of carcinoma of the prostate. J.A.M.A., 160: 833, 1956. Google Scholar 4 Shelley, H. S., Auerbach, S. H., Classen, K. L., Marks, C. H. and Wiederanders, R. E.: Carcinoma of the prostate. A new system of classification. Arch. Surg., 77: 751, 1958. Google Scholar 5 Emmett, J. L., Greene, L. F. and Papantoniou, A.: Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies. J. Urol., 83: 471, 1960. Google Scholar 6 Vickery, A. L. and Kerr, W. S., Jr.: Carcinoma of the prostate treated by radical prostatectomy. A clinicopathological survey of 187 cases followed for 5 years and 148 cases followed for 10 years. Cancer, 16: 1598, 1963. Google Scholar 7 Wiederanders, R. E., Stuber, R. V., Mota, C., O'Connell, D. and Haslam, G. J.: Prognostic value of grading prostatic carcinoma. J. Urol., 89: 881, 1963. Google Scholar 8 Mellinger, G. T., Gleason, D. and Bailar, J. C., III. The histology and prognosis of prostatic cancer. J. Urol., 97: 331, 1967. Google Scholar 9 Corriere, J. N., Jr., Cornog, J. L. and Murphy, J. J. Prognosis in patients with carcinoma of the prostate. Cancer, 25: 911, 1970. Google Scholar 10 Belt, E. and Schroeder, F. H.: Total perineal prostatectomy for carcinoma of the prostate. J. Urol., 107: 91, 1972. Google Scholar 11 Hanash, K. A., Utz, D. C., Cook, E. N., Taylor, W. F. and Titus, J. L.: Carcinoma of the prostate: a 15-year followup. J. Urol., 107: 450, 1972. Google Scholar 12 The Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: treatment comparisons. J. Urol., 98: 516, 1967. Google Scholar 13 The Veterans Administration Co-operative Urological Research Group: Treatment and survival of patients with cancer of the prostate. Surg. Gynec. & Obst., 124: 1011, 1967. Google Scholar 14 Bailar, J. C., III and Byar, D. P.: Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo. Cancer, 26: 257, 1970. Google Scholar © 2002 by American Urological Association, Inc.®FiguresReferencesRelatedDetails Volume 197Issue 2SFebruary 2017Page: S134-S139 Advertisement Copyright & Permissions© 2002 by American Urological Association, Inc.®MetricsAuthor Information Donald F. Gleason More articles by this author George T. Mellinger More articles by this author The Veterans Administration Cooperative Urological Research Group† Members of this group are: Lino J. Arduino, Veterans Administration Center (VAC), Des Moines, Ipwa; John C. Bailar, III, Veterans Administration Central Office (VACO), Washington, D. C.; Leslie E. Becker, VAC, Leavenworth, Kansas; Henry I. Berman, Veterans Administration Hospital (VAH), Louisville, Kentucky; Arthur J. Bischoff, VAH, Long Beach, California; David P. Byar, National Cancer Institute, Bethesda, Maryland; Clyde E. Blackard, VAH, Minneapolis, Minnesota; Richard P. Doe, VAH, Minneapolis, Minnesota; James S. Elliot, VAH, Palo Alto, California; Earl Haltiwanger, VAH, Atlanta, Georgia; Robert B. Higgins, VAH, Portland, Oregon; Joseph Jorgens, VAC, Los Angeles, California; Howard C. Kramer, VAH, Baltimore, Maryland; Lyndon E. Lee, Jr., VACO, Washington, D. C.; Maxwell Malament, VAH, East Orange, New Jersey; F. K. Mostofi, Armed Forces Institute of Pathology, Washington, D. C.; William L. Parry, VAH, Oklahoma City, Oklahoma; Lloyd S. Rogers, VAH, Syracuse, New York; A. Hardy Ulm, III, VAH, New York, New York and Venancio R. Quiambao, VAH, Cincinnati, Ohio. More articles by this author Expand All Advertisement PDF downloadLoading ...